The Goldman Sachs Group Initiates Coverage on Accelevation (NASDAQ:ACCV)

Research analysts at The Goldman Sachs Group assumed coverage on shares of Accelevation (NASDAQ:ACCV – Get Free Report) in a research report issued on Monday, MarketBeat.com reports. The brokerage set a “buy” rating and a $22.00 price target on the stock. The Goldman Sachs Group‘s target price would indicate a potential upside of 68.58% from the stock’s current price.

Several other equities analysts also recently weighed in on ACCV. Wolfe Research began coverage on shares of Accelevation in a report on Monday. They issued an “outperform” rating on the stock. Robert W. Baird started coverage on shares of Accelevation in a research note on Monday. They set an “outperform” rating and a $16.00 target price on the stock. Bank of America started coverage on shares of Accelevation in a research note on Monday. They issued a “buy” rating and a $20.00 price target on the stock. Morgan Stanley initiated coverage on Accelevation in a report on Monday. They issued an “equal weight” rating and a $18.00 price objective on the stock. Finally, Barclays began coverage on shares of Accelevation in a report on Monday. They set an “overweight” rating and a $20.00 target price for the company. Two equities research analysts have rated the stock with a Strong Buy rating, five have assigned a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat.com, Accelevation currently has a consensus rating of “Buy” and a consensus target price of $19.43.

Get Our Latest Report on Accelevation

Accelevation Price Performance

Accelevation stock opened at $13.05 on Monday. Accelevation has a one year low of $11.58 and a one year high of $18.10.

Insider Buying and Selling at Accelevation

In other news, COO Brent Jewell bought 2,500 shares of the business’s stock in a transaction that occurred on Thursday, October 1st. The shares were purchased at an average cost of $18.00 per share, for a total transaction of $45,000.00. Following the completion of the purchase, the chief operating officer owned 304,068 shares of the company’s stock, valued at approximately $5,473,224. This represents a 0.83% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Michael Rubiera acquired 200,000 shares of the company’s stock in a transaction on Thursday, October 1st. The stock was purchased at an average cost of $18.00 per share, for a total transaction of $3,600,000.00. Following the completion of the transaction, the chief executive officer owned 1,424,285 shares in the company, valued at approximately $25,637,130. The trade was a 16.34% increase in their position. The SEC filing for this purchase provides additional information. In the last 90 days, insiders acquired 227,700 shares of company stock valued at $4,098,600.

Key Stories Impacting Accelevation

Here are the key news stories impacting Accelevation this week:

• Positive Sentiment: New bullish coverage: JPMorgan initiated coverage with an Overweight rating and a $20 price target, while Bank of America also began coverage with a Buy rating and a $20 target. These targets imply substantial potential appreciation and may improve investor sentiment. JPMorgan Initiates Accelevation at Overweight With $20 Price Target
• Positive Sentiment: Additional outperform ratings: Baird, Wolfe Research and William Blair each rated ACCV Outperform. Baird assigned a $16 price target, adding to the consensus of favorable views from newly initiated coverage. Baird Initiates Accelevation at Outperform With $16 Price Target
• Neutral Sentiment: Morgan Stanley takes a balanced view: The firm initiated coverage at Equal Weight with an $18 price target, citing strong data-center fundamentals but also long-term uncertainty about hyperscaler capital spending. Its research frames ACCV as a growth opportunity with meaningful execution and industry risks. Accelevation rated Equal Weight in new research by Morgan Stanley
• Negative Sentiment: Short-interest data is inconsistent: One report cited 2.84 million shares sold short, equal to 1.3% of shares outstanding and 1.1 days to cover, suggesting some bearish positioning. A separate report listed zero short interest, so investors should treat the figures cautiously until the discrepancy is clarified.

About Accelevation

(Get Free Report)

Accelevation Corporation NASDAQ: ACCV is a special purpose acquisition company (SPAC) formed to identify and combine with an operating business through a merger, share exchange, asset acquisition, reorganization or similar transaction.

Unlike an operating company, Accelevation does not manufacture products, provide ongoing commercial services or conduct significant business activities of its own. Its primary activities have consisted of evaluating potential acquisition targets and pursuing a business combination.

Public information about Accelevation’s operating history, geographic footprint and leadership is limited.

Featured Articles

• Five stocks we like better than Accelevation
• A Solid Margin Story Means the Sell-Off in DECK May Be Overdone
• Verizon’s Q3 Results Show Why SpaceX’s Spectrum Grab Isn’t a Major Threat
• Comfort Systems Earnings: AI Slowdown or More Growth Ahead?
• Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock

Should You Invest $1,000 in Accelevation Right Now?

Before you consider Accelevation, you’ll want to hear this.

MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Accelevation wasn’t on the list.

While Accelevation currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here